Breast Cancer: New Eye Safety Drug Study

We are investigating the safety of a new drug for breast cancer patients, specifically looking at its effects on eye health. This study aims to ensure that the treatment does not harm vision.

>2 yearsSafety phase (I)OncologyOphthalmology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
UZ Leuven
Gynaecological Oncology Department
Heverlee, Belgium
Centre Hospitalier Regional De La Citadelle
Medical Oncology Department
Liège, Belgium
Antwerp University Hospital
Oncology Department
Wilrijk, Belgium

Sponsor: AstraZeneca AB
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.